Companies / Fortress Biotech, Inc. / Activity
Activity — Fortress Biotech, Inc.
7 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 1, 2026 | Lorenz Kevin Director | Grant | common stock, par value $0.001 | $0 | +27K +37.08% | 101,009 0.28% of shares | low |
| Jan 1, 2026 | Klein Dov Director | Grant | common stock, par value $0.001 | $0 | +27K +26.58% | 130,105 0.36% of shares | low |
| Jan 1, 2026 | Harvey Jimmie Director | Grant | common stock, par value $0.001 | $0 | +27K +22.89% | 146,704 0.40% of shares | low |
| Mar 18, 2026 | Weiss Michael S Executive | Grant | common stock, par value $0.001 | $0 | +475K +26.40% | 2,276,562 6.21% of shares | low |
| Mar 18, 2026 | Lindsay A. Rosenwald, M.D. CEO | Grant | Common stock, par value $0.001 | $0 | +475K +11.56% | 4,586,841 12.52% of shares | low |
| Jan 1, 2026 | Hoenlein Malcolm Director | Grant | Common Stock, par value $0.001 | $0 | +27K +30.90% | 115,747 0.32% of shares | low |
| Jan 1, 2026 | Lobell J Jay Director | Grant | common stock, par value $0.001 | $0 | +27K +16.55% | 192,397 0.53% of shares | low |